2016 EHA Annual Meeting Highlights in HL


Updates from the German Hodgkin Study Group (GHSG)
Peter Borchmann, MD

Begin


Real-World Data on Brentuximab Vedotin in Hodgkin Lymphoma
Paul Bröckelmann, MD

Begin


PET-Adapted Therapy in Hodgkin Lymphoma
Astrid Pavlovsky, MD

Begin


Immuno-oncology in Hodgkin Lymphoma
Anas Younes, MD

Begin

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2017 MediCom Worldwide, Inc. All rights reserved